10/28/2021

speaker
Operator
Conference Operator

Good morning ladies and gentlemen and thank you for standing by. Welcome to the Invercare third quarter 2021 conference call and webcast. After the management overview, we'll be open to the call to questions. Investors and analysts interested in asking questions will need to dial in as questions cannot be submitted via the webcast. For the first part of the call, all phone lines have been placed on mute. This conference is being recorded Thursday, October 28th, 2021. I'll now turn the call over to Lewis Lee of Invacare's Director of Treasury Investor Relations and Corporate Communications. Thank you.

speaker
Lewis Lee
Director of Treasury, Investor Relations and Corporate Communications

Thank you. Joining me on today's call from Invacare are Matt Monaghan, Chairman, President and Chief Executive Officer, and Kathy Monaghan, Senior Vice President and Chief Financial Officer. Today, we will be reviewing our third quarter 2021 finance results and providing investors with an update on our full year outlook. To help investors follow along, we have created slides to accompany this webcast. For those dialing in, you can find a link to our webcast slide presentation at global.invocare.com slash investor dash relations. Further information can be found on our SEC filing. Before Matt begins, I'd like to note that during today's call, we may make forward-looking statements about the company that by their nature address matters that are uncertain. Actual future results may differ materially from those expressed in our statements today due to various uncertainties, and I refer you to the cautionary statement included on the second page of our webcast slide and in our third quarter earnings release. For an explanation of the items discussed on today's calls that are considered to be non-GAAP financial information, such as constant currency net sales, constant currency SG&A, free cash flow, and adjusted interest costs, Please see the notes in the appendix of our webcast slide and in the related reconciliations in the slides and in the earnings release posted on our website. I will now turn the call over to Matt.

speaker
Matt Monaghan
Chairman, President and Chief Executive Officer

Thank you, Lois. Good morning. Starting on slide three, I'm pleased to announce that we achieved constant currency net sales growth of 2.9% with increases in all key product categories despite continuing global supply chain challenges. Revenue growth was led by solid performance in Europe and Asia Pacific, and North America realized growth in mobility and seating and respiratory products, Compared with strong new order intake, we continue to experience higher than typical backlog levels across all product categories compared to pre-pandemic levels, which is expected to drive sequential sales growth in the fourth quarter. As always, we're working diligently to maximize our throughput and improve our service levels to better support our customers' needs. Turning to gross profit, we benefited from sales growth and favorable sales mix with higher gross profit on lower percentage of sales, Gross margin was impacted by previously disclosed changes to input costs ahead of offsetting price adjustments. We view these challenges as transitory, and during the quarter, we undertook actions to address them, which I'll discuss more in detail on the next slide. To support existing levels of demand and expected sales growth, free cash flow usage increased as a result of greater investment in working capital, specifically inventory, which Kathy will discuss later. Overall, our sales results were in line with expectations, with solid revenue growth year over year in all major product categories. Turning to slide four, we expect to finish the year on a strong note. While we anticipate global supply chain challenges to persist in the near term, the disruptions are generally more predictable, and the actions we've taken should mitigate some of the remaining uncertainty. In addition, our customers continue to demonstrate strong demand for our products, even though access to healthcare has not fully rebounded from pre-pandemic levels. As mentioned previously, we're taking action to mitigate the supply chain challenges which impacted sales and gross margin. For example, we've expanded our network of freight providers for more timely shipment. We found ways to improve staffing levels to increase throughput, and we have further increased inventory to mitigate supply chain uncertainty. In addition, we continue to adjust price and freight charges where applicable to offset the substantially higher material and logistics costs we continue to experience. While still early in the fourth quarter, we're seeing positive signs that our actions should be effective. As we work through these near-term challenges, we are also marching forward with the next phase of our IT modernization initiative in North America. I'm pleased to share that the program took a big step forward following the launch of our new e-commerce platform, which has features to enhance customers' experience and to improve the ease of doing business with Indicare. In 2022, we expect to launch the next phase in North America, which will focus on driving operational efficiencies, lowering costs, and improving working capital management. Turning to sales. Demand remains strong, and we continue to see solid order rates in all regions and product categories. As we grow revenue, our order backlog has also continued to increase. In the third quarter, product availability and our targeted inventory strategy were key factors in driving strong sales growth in both Europe and Asia Pacific. Specific material shortages limited some of lifestyle product availability in North America, balancing overall results. All things taken together, we expect fourth quarter will improve in all key metrics with sequential constant currency net sales growth driving substantially higher profitability and free cash flow. We believe the progress we have made sets us up for a strong finish to the year and continued improvement in 2022. I'll now turn the call over to Kathy who will provide a detailed financial summary.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-